相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ciclopirox olamine induces ferritinophagy and reduces cyst burden in polycystic kidney disease
Priyanka S. Radadiya et al.
JCI INSIGHT (2021)
Antifibrotic Synergy Between Phosphodiesterase Type 5 Inhibitors and Selective Oestrogen Receptor Modulators in Peyronie's Disease Models
Marcus M. Ilg et al.
EUROPEAN UROLOGY (2019)
Quality Control of Quantitative High Throughput Screening Data
Keith R. Shockley et al.
FRONTIERS IN GENETICS (2019)
Topical Ciclopirox Olamine 1%: Revisiting a Unique Antifungal
Sidharth Sonthalia et al.
INDIAN DERMATOLOGY ONLINE JOURNAL (2019)
The Role of Macrophages in Acute and Chronic Wound Healing and Interventions to Promote Pro-wound Healing Phenotypes
Paulina Krzyszczyk et al.
FRONTIERS IN PHYSIOLOGY (2018)
Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
Ana L. Mora et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Small molecule-mediated inhibition of myofibroblast transdifferentiation for the treatment of fibrosis
Michael J. Bollong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
A prospective study of time to healing and hypertrophic scarring in paediatric burns: every day counts
Elizabeth Chipp et al.
BURNS & TRAUMA (2017)
Vimentin coordinates fibroblast proliferation and keratinocyte differentiation in wound healing via TGF-β-Slug signaling
Fang Cheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Current concepts related to hypertrophic scarring in burn injuries
Ryan S. Chiang et al.
WOUND REPAIR AND REGENERATION (2016)
Dissecting fibrosis: therapeutic insights from the small-molecule toolbox
Carmel B. Nanthakumar et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Developing predictive assays: The phenotypic screening rule of 3
Fabien Vincent et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Challenges in the Treatment of Chronic Wounds
Robert G. Frykberg et al.
ADVANCES IN WOUND CARE (2015)
Up-to-date approach to manage keloids and hypertrophic scars: A useful guide
Anna I. Arno et al.
BURNS (2014)
Update on hypertrophic scar treatment
Felipe Bettini Rabello et al.
CLINICS (2014)
Wound repair and regeneration: Mechanisms, signaling, and translation
Sabine A. Eming et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Cytokine mediated tissue fibrosis
Lee A. Borthwick et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Skin uptake and clearance of ciclopirox following topical application
Anroop B. Nair et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2013)
Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines
D. C. Swinney
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Complementary effects of ciclopirox olamine, a prolyl hydroxylase inhibitor and sphingosine 1-phosphate on fibroblasts and endothelial cells in driving capillary sprouting
Sei Hien Lim et al.
INTEGRATIVE BIOLOGY (2013)
Theoretical and Experimental Relationships between Percent Inhibition and IC50 Data Observed in High-Throughput Screening
Hanspeter Gubler et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Thomas A. Wynn et al.
NATURE MEDICINE (2012)
Primary Cells and Stem Cells in Drug Discovery: Emerging Tools for High-Throughput Screening
Richard Eglen et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2011)
Novel therapeutic approaches for pulmonary fibrosis
Arnab Datta et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Wnt Inhibitor Screen Reveals Iron Dependence of β-Catenin Signaling in Cancers
Siyuan Song et al.
CANCER RESEARCH (2011)
Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies
Gerd G. Gauglitz et al.
MOLECULAR MEDICINE (2011)
How were new medicines discovered?
David C. Swinney et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Antimycotic Ciclopirox Olamine in the Diabetic Environment Promotes Angiogenesis and Enhances Wound Healing
Sae Hee Ko et al.
PLOS ONE (2011)
Ciclopirox Recent Nonclinical and Clinical Data Relevant to its Use as a Topical Antimycotic Agent
Alessandro Subissi et al.
DRUGS (2010)
Differential apoptosis markers in human keloids and hypertrophic scars fibroblasts
Bruna De Felice et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
Keratinocyte-fibroblast interactions in wound healing
Sabine Werner et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Fas-mediated apoptotic signal transduction in keloid and hypertrophic scar
Feng Lu et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2007)
Fibroblasts and myofibroblasts: Their source, function and role in disease
Robin J. McAnulty
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Evidence for the link between healing time and the development of hypertrophic scars (HTS) in paediatric burns due to scald
Tania C. S. Cubison et al.
BURNS (2006)
SB-505124 is a selective inhibitor of transforming growth factor-β type I receptors ALK4, ALK5, and ALK7
SD Byfield et al.
MOLECULAR PHARMACOLOGY (2004)
Seborrheic dermatitis
AK Gupta et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2004)
The antimycotic ciclopirox olamine induces HIF-1α stability, VEGF expression, and angiogenesis
T Linden et al.
FASEB JOURNAL (2003)
The antifungal drug ciclopirox inhibits deoxyhypusine and proline hydroxylation, endothelial cell growth and angiogenesis in vitro
PMJ Clement et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
分享论文
